Navigation Links
Kensey Nash Corporation Announces Its Second Quarter 2008 Earnings Release Date and Teleconference
Date:1/4/2008

e Company's significant expertise in the design, development, manufacturing and processing of absorbable biomaterials, which has led to partnerships to commercialize technologies. Kensey Nash has also commercialized a series of innovative products through its own direct endovascular sales force. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc.


'/>"/>
SOURCE Kensey Nash Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Kensey Nash Corporation Announces its First Quarter 2008 Earnings Release Date and Teleconference
2. Kensey Nash Announces $25 Million Stock Repurchase Program
3. Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20% of Outstanding Shares
4. Kensey Nash Reports First Quarter Fiscal Year 2008 Results
5. Kensey Nash Announces Exclusive License of Optical Guidance Patent to Enhance Chronic Total Occlusion Platform
6. Kensey Nash to Present at the 19th Annual Piper Jaffray Health Care Conference
7. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
8. Brooke Franchise Corporation Announces Selected July Results
9. MedThink Communications Retained by NanoBio Corporation
10. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
11. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)... Protect Investment And Restore Shareholder Value ...ire/ -- Dr. Stephen Joffe, Craig Joffe, and Alan B...3D with the U.S. Securities and Exchange Commissio...nership of 11.4% of LCA-Vision, Inc. (Nasdaq: LC... vision correction centers in 33 states in the Uni...
(Date:11/21/2008)...stCall/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL...ingly approved the proposals submitted to them rel...ticals Industries Ltd. (Nasdaq: TEVA ). , ,...pport of the transaction by the Barr shareholders,...We are pleased with the progress that we continue ...
(Date:11/21/2008)...atewide survey, 33 physicians credentialed to prac...erian Hospital of Dallas were honored by Texas Mo...rs ." , , Each year, the publishers of Tex... to survey more than 38,000 medical professionals ...edical care, which doctor would you choose?" Key ...
(Date:11/21/2008)...ope Research(TM), a revolutionary,biometric media...Measurement,announced today the appointment of t... research and development, business strategy and m...ents, who deliver a combined 60 years of experienc...er and Vice President of,Strategy; Dr. Ravi Kothu...
Breaking Medicine News(10 mins):Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 4Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 5Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 6Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 7Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4Health News:Annual List of 'Super Doctors' Features 33 Texas Institute for Surgery Physicians 2Health News:Innerscope Research Strengthens Management Team With Three Executive Appointments 2
...dministration ordered the makers of ADHD drugs to ...ients, the significant// ones being psychiatric an...or of the FDA’s Center for Drug Evaluation and Res... immensely useful in treating patients with ADHD, ...
... degeneration (AMD) is the leading cause of visual...50, affecting// more than two million people. Th...d people that although AMD is incurable, there are...sually recover lost vision and prevent further vis...
... safe and healthy multivitamin? Vitamins and Miner...ard Medical School//, offers the following advice....t bear the U.S. Pharmacopeia Dietary Supplement Ve... mark, which indicates that the manufacturer has c...
...dia has immensely deteriorated over the last seven...t victims//, top UNICEF officials said Wednesday. ...I, (NFHS-3), over 56.2 percent married women in th...49 were anemic in 2006 as against 51.8 percent in ...
Other Medicine News:Health News:Spring is Time for Age-Related Macular Degeneration (AMD) Awareness 2Health News:Married Women, Children Most Anemic in India 2
(Date:11/21/2008).../ -- Ikaria Holdings, Inc. today announced that it... New Jersey Technology Council (NJTC), a 1,200-mem... support, networking opportunities, information an...ers. Ikaria earned the award based on criteria inc...e provision. , , "We are delighted that the...
(Date:11/20/2008)...F FIRST PHASE III TRIAL SHOW SIGNIFICANT, DEC...LY FUNCTION, IN, FIBRO...SSELS, Belgium, Nov. 20 /PRNewswire-FirstCall/,--...UCB (Euronext Brussels: UCB),announced today posi...f two,Phase III pivotal clinical trials of sodium...
(Date:11/20/2008)...ire/ -- Radius Health ("Radius") announced today t... second institutional financing round, increasing ... total amount raised since the company,s inception...estors participated in the financing, led by MPM B..., The Wellcome Trust, HealthCare Ventures, Oxford ...
(Date:11/19/2008)...Newswire-FirstCall/ -- Amgen,(Nasdaq: AMGN ) an...diary of,Takeda Pharmaceutical Company Limited (T... Phase 3 MONET1 trial evaluating motesanib (AMG 70... for the first-line treatment of,advanced non-sma...uspended,following a planned safety data review o...
Breaking Medicine Technology:Ikaria(R) Named Private Company of the Year by New Jersey Technology Council 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 3Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 4Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 5Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 6Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7Physicians Health Choice Hires Blue Clover as Agency of Record 26590 1Physicians Health Choice Hires Blue Clover as Agency of Record 26590 2AdvaMed 2008 Sponsor Participation Increases by 52 25 26587 1AdvaMed 2008 Sponsor Participation Increases by 52 25 26587 2AdvaMed 2008 Sponsor Participation Increases by 52 25 26587 3AdvaMed 2008 Sponsor Participation Increases by 52 25 26587 4DRE Medical Equipment Offers Valuable Discounts to GE Healthcare Customers 26586 1DRE Medical Equipment Offers Valuable Discounts to GE Healthcare Customers 26586 2Baby Boomers 26apos 3B Aging Wave Affects Social Security Disability Program 26583 1Baby Boomers 26apos 3B Aging Wave Affects Social Security Disability Program 26583 2Baby Boomers 26apos 3B Aging Wave Affects Social Security Disability Program 26583 3Baby Boomers 26apos 3B Aging Wave Affects Social Security Disability Program 26583 4Baby Boomers 26apos 3B Aging Wave Affects Social Security Disability Program 26583 5
..., 2007 - Advanced Viral,Research Corp. (OTC Bullet...unced today that new information on AVR118 has bee... of the American,Society of Clinical Oncology (ASC...distributed to the nearly 25,000 oncology,praction...hicago on,June 1-5., Based on recent work conducte...
...s Across the Genome From 242,Patients and Identifi...astic Leukemia, Suggesting New Targets for Improve...ire/ -- Investigators at,St. Jude Children,s Resea...d mutations that contribute to the formation of pe...st common cancer in,children. The discovery not on...
Other Medicine Technology:American Society of Clinical Oncology (ASCO) Accepts New Data on,AVR118 for Publication in 2007 Abstract Book 2American Society of Clinical Oncology (ASCO) Accepts New Data on,AVR118 for Publication in 2007 Abstract Book 3Major Gene Study Uncovers Secrets of Leukemia 2Major Gene Study Uncovers Secrets of Leukemia 3
Medium Surgical Clips. 6 clips per cartridge. Box of 30 cartridges with a total of 180 titanium clips per box. For secure vasal and other occlusion.
Sterile Disposable Thermal Cautery Tips for Vasectomy. Individually peel-pouched with dual plastic sheaths to cover non-sterile handle. Box of 10 tips.
Li Brand™ Surgical Hemostat. ("dissecting clamp") For NSV and other procedures.
Platinum General Purpose Cautery Electrodes , ,A - Loop Tip, ,Fully autoclavable. Tips typically last for 50 to 100 or more procedures, depending on burn time.
Medicine Products: